210 related articles for article (PubMed ID: 1283768)
1. The sympathetic nervous system may modulate the metabolic cardiovascular syndrome in essential hypertension.
Kjeldsen SE; Rostrup M; Moan A; Mundal HH; Gjesdal K; Eide IK
J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S32-9. PubMed ID: 1283768
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance in hypertension--a relationship with consequences?
Berne C
J Intern Med Suppl; 1991; 735():65-73. PubMed ID: 2043224
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
4. [Hypertension as a part of metabolic cardiovascular syndrome].
Os I; Hjermann I; Nordby G
Tidsskr Nor Laegeforen; 1991 Oct; 111(25):3062-4. PubMed ID: 1948918
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure.
Egan BM; Papademetriou V; Wofford M; Calhoun D; Fernandes J; Riehle JE; Nesbitt S; Michelson E; Julius S;
Am J Hypertens; 2005 Jan; 18(1):3-12. PubMed ID: 15691610
[TBL] [Abstract][Full Text] [Related]
6. Elevated heart rate as a predictor of increased cardiovascular morbidity.
Palatini P
J Hypertens Suppl; 1999 Aug; 17(3):S3-10. PubMed ID: 10489092
[TBL] [Abstract][Full Text] [Related]
7. Metabolic and adrenergic characteristics of young men with insulin resistance.
Moan A; Eide IK; Kjeldsen SE
Blood Press Suppl; 1996; 1():30-7. PubMed ID: 9162435
[TBL] [Abstract][Full Text] [Related]
8. Sympathetic nervous system: contribution to human hypertension and related cardiovascular diseases.
Esler M
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S24-8. PubMed ID: 8642801
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome and new category 'pre-hypertension' in a Japanese population.
Kanauchi M; Kanauchi K; Hashimoto T; Saito Y
Curr Med Res Opin; 2004 Sep; 20(9):1365-70. PubMed ID: 15383184
[TBL] [Abstract][Full Text] [Related]
11. The role of norepinephrine and insulin resistance in an early stage of hypertension.
Penesova A; Radikova Z; Cizmarova E; Kvetnanský R; Blazicek P; Vlcek M; Koska J; Vigas M
Ann N Y Acad Sci; 2008 Dec; 1148():490-4. PubMed ID: 19120146
[TBL] [Abstract][Full Text] [Related]
12. Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors?
Lind L; Lithell H; Pollare T
J Hypertens Suppl; 1993 Jun; 11(4):S11-6. PubMed ID: 8377030
[TBL] [Abstract][Full Text] [Related]
13. [Insulin resistance syndrome and hypertension].
Shimamoto K
Hokkaido Igaku Zasshi; 2000 Jan; 75(1):9-14. PubMed ID: 10736756
[TBL] [Abstract][Full Text] [Related]
14. [Insulin, nitric oxide and the sympathetic nervous system: from crossroads to metabolic and cardiovascular homeostasis].
Sartori C; Thalmann S; Jayet PY; Duplain H; Vollenweider P; Scherrer U
Rev Med Suisse Romande; 2004 Oct; 124(10):635-8. PubMed ID: 15573509
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome in subjects with essential hypertension: relationships with subclinical cardiovascular and renal damage.
Mulé G; Cottone S; Nardi E; Andronico G; Cerasola G
Minerva Cardioangiol; 2006 Apr; 54(2):173-94. PubMed ID: 16778751
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance in essential hypertension: a psychophysiological approach to the "chicken and egg" question.
Nazzaro P; Triggiani R; Ciancio L; Scarano AM; Pirrelli AM
Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):275-86. PubMed ID: 11213537
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence.
Aizawa Y; Kamimura N; Watanabe H; Aizawa Y; Makiyama Y; Usuda Y; Watanabe T; Kurashina Y
Int J Cardiol; 2006 May; 109(2):213-8. PubMed ID: 16023231
[TBL] [Abstract][Full Text] [Related]
19. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
20. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
Bigazzi R; Bianchi S; Batini V; Guzzo D; Campese VM
Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
